Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma

France Nouvelles Nouvelles

Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma
France Dernières Nouvelles,France Actualités
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

Merck & Co. and Moderna Inc. said Wednesday they have launched a Phase 3 trial of Moderna’s V940 in combination with Merck’s Keytruda as a treatment for...

Merck & Co. MRK and Moderna Inc.

said Wednesday they have launched a Phase 3 trial of Moderna’s V940 in combination with Merck’s Keytruda as a treatment for patients with high-risk, or Stage IIB-IV melanoma. The trial is the first Phase 3 study of a planned comprehensive clinical development program being initiated following positive data from a Phase 2 trial that was reported at two cancer conferences, AACR and ASCO, earlier this year.

said Wednesday they have launched a Phase 3 trial of Moderna’s V940 in combination with Merck’s Keytruda as a treatment for patients with high-risk, or Stage IIB-IV melanoma. The trial is the first Phase 3 study of a planned comprehensive clinical development program being initiated following positive data from a Phase 2 trial that was reported at two cancer conferences, AACR and ASCO, earlier this year.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

MarketWatch /  🏆 3. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Psychedelic psilocybin could treat anorexia in some patients, trial suggestsPsychedelic psilocybin could treat anorexia in some patients, trial suggestsTen patients with anorexia were treated with psilocybin and reported a positive experience, and four experienced remission of their symptoms.
Lire la suite »

Jury Deliberates In Kevin Spacey TrialJury Deliberates In Kevin Spacey TrialThe jury in the sex offences trial of Oscar-winning actor Kevin Spacey has been sent out to begin its deliberations. The 63-year-old Hollywood star denies nine charges including sexual assault, whi…
Lire la suite »

Kevin Spacey Trial: Jury Retires to Deliberate on VerdictKevin Spacey Trial: Jury Retires to Deliberate on VerdictAfter four weeks hearing evidence from four accusers, plus friends and family, the jury is considering eight charges, including indecent assault, sexual assault and the most serious, “causing a person to engage in penetrative sexual activity.'
Lire la suite »

How The Kevin Spacey Trial Has Played Out So FarHow The Kevin Spacey Trial Has Played Out So FarOne of the highest-profile entertainment biz legal cases ever has been playing out in a London courtroom over the past month, and Deadline has been following every step of the way. The jury has jus…
Lire la suite »

WATCH LIVE: Timothy Simpkins takes the stand, sentencing continues in Timberview HS shooting trialWATCH LIVE: Timothy Simpkins takes the stand, sentencing continues in Timberview HS shooting trialA Tarrant County jury found Timothy George Simpkins, a man accused of shooting three people at Timberview High School in Arlington in 2021 after a fight in a classroom, guilty of attempted capital murder on Thursday.
Lire la suite »

Judge Cannon could still 'derail' hopes of quick Trump trial: Ex-prosecutorJudge Cannon could still 'derail' hopes of quick Trump trial: Ex-prosecutorThe former president's federal criminal trial in the classified documents case is currently set to begin on May 20, 2024.
Lire la suite »



Render Time: 2025-03-03 13:37:10